JHS Svendgaard Laboratories Limited (IN:JHS)
:JHS
Want to see IN:JHS full AI Analyst Report?
Top Page
JHS Svendgaard Laboratories Limited
(JHS)
Select Model
Select Model
Rating:48Neutral
Price Target:
₹9.00
▼(-3.64% Downside)
Action:Reiterated
Date:05/31/26
Overall score is held back primarily by weak financial performance—ongoing losses and recurring cash burn despite a FY2026 revenue rebound—partly offset by a relatively solid, low-leverage balance sheet. Technicals are modestly supportive in the near term, while valuation is not compelling given negative earnings and no dividend data.
Positive Factors
Low leverage / strong balance sheet
Low leverage and a stable equity base materially reduce solvency and refinancing risk over the medium term. This financial flexibility supports continued operations, selective capex or working-capital needs and gives management time to execute a turnaround without immediate pressure to deleverage.
Negative Factors
Ongoing losses and negative margins
Persistent negative net margins mean the firm has not yet converted revenue into shareholder returns, weighing on return metrics and reinvestment capability. Continued losses erode equity over time and limit management's ability to fund growth internally without altering cost structure or pricing.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
Low leverage and a stable equity base materially reduce solvency and refinancing risk over the medium term. This financial flexibility supports continued operations, selective capex or working-capital needs and gives management time to execute a turnaround without immediate pressure to deleverage.
Read all positive factors
JHS Svendgaard Laboratories Limited (JHS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹733.63M
Dividend YieldN/A
Average Volume (3M)16.78K
Price to Earnings (P/E)―
Beta (1Y)1.12
Revenue Growth10.54%
EPS Growth90.30%
CountryIN
Employees250
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-0.95
Shares Outstanding85,603,966
10 Day Avg. Volume16,348
30 Day Avg. Volume16,781
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)0.33
Price to Sales (P/S)0.56
P/FCF Ratio-3.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JHS Svendgaard Laboratories Limited Business Overview & Revenue Model
Company Description
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash produ...
How the Company Makes Money
JHS makes money primarily through the sale of finished goods in oral care and personal care categories and through manufacturing services for third parties. Key revenue streams typically include: (1) branded product sales, where JHS sells its own ...
JHS Svendgaard Laboratories Limited Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
72
Positive
Cash Flow
24
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 935.64M | 1.02B | 919.97M | 698.06M | 840.82M | 854.91M |
| Gross Profit | 329.55M | 177.22M | 309.55M | 203.55M | 165.45M | 201.68M |
| EBITDA | -15.86M | 26.15M | -39.92M | 33.78M | -163.82M | 85.45M |
| Net Income | -79.38M | -19.22M | -197.44M | -40.58M | -175.17M | -40.52M |
Balance Sheet | ||||||
| Total Assets | 2.07B | 2.15B | 2.01B | 1.97B | 2.28B | 2.22B |
| Cash, Cash Equivalents and Short-Term Investments | 200.11M | 191.00M | 200.16M | 94.56M | 386.51M | 80.19M |
| Total Debt | 105.87M | 148.51M | 64.58M | 51.29M | 155.09M | 61.82M |
| Total Liabilities | 332.52M | 405.49M | 284.41M | 271.70M | 543.87M | 269.46M |
| Stockholders Equity | 1.74B | 1.75B | 1.73B | 1.70B | 1.74B | 1.86B |
Cash Flow | ||||||
| Free Cash Flow | -29.85M | -148.91M | -157.11M | -401.17M | 89.43M | -158.75M |
| Operating Cash Flow | -29.85M | -20.97M | -51.78M | -85.84M | 232.86M | -91.36M |
| Investing Cash Flow | 92.77M | -130.38M | -220.18M | -217.34M | 96.77M | -46.97M |
| Financing Cash Flow | 38.02M | 121.43M | 232.97M | 21.74M | -9.00M | -16.72M |
JHS Svendgaard Laboratories Limited Technical Analysis
Negative
9.34
Price Trends
8.57
Negative
9.27
Negative
10.27
Negative
Market Momentum
>-0.01
Positive
45.81
Neutral
31.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JHS, the sentiment is Negative. The current price of 9.34 is above the 20-day moving average (MA) of 8.79, above the 50-day MA of 8.57, and below the 200-day MA of 10.27, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.81 is Neutral, neither overbought nor oversold. The STOCH value of 31.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JHS.
JHS Svendgaard Laboratories Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ₹545.06B | 41.04 | ― | 2.42% | -0.08% | -7.76% | |
75 Outperform | ₹753.73B | 39.66 | ― | 1.62% | 5.01% | 7.14% | |
69 Neutral | ₹171.61B | 21.67 | ― | 1.91% | -0.78% | -3.87% | |
64 Neutral | ₹135.60B | 67.60 | ― | ― | 15.72% | 174.63% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ₹1.02T | 54.80 | ― | 1.67% | 7.81% | 0.51% | |
48 Neutral | ₹733.63M | -38.77 | ― | ― | 10.54% | 90.30% |
* Consumer Defensive Sector Average
IN:JHS
JHS Svendgaard Laboratories Limited
8.72
-4.29
-32.97%
IN:COLPAL
Colgate-Palmolive (India) Limited
1,999.35
-382.18
-16.05%
IN:DABUR
Dabur India Limited
424.10
-49.86
-10.52%
IN:EMAMILTD
Emami Limited
385.20
-186.58
-32.63%
IN:GODREJCP
Godrej Consumer Products Limited
998.65
-190.39
-16.01%
IN:HONASA
Honasa Consumer Limited
415.90
96.10
30.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.